Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

Manno, C. S., Pierce, G. F., Arruda, V. R., Glader, B., Ragni, M., Rasko, J. J. E., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1358 · Cited by 2,163 · see citing works

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520 · see citing works

Repeat-induced gene silencing in mammals

Garrick, D., Fiering, S., Martin, D. I. K., & Whitelaw, E. (1998) · Nature Genetics · doi:10.1038/ng0198-56 · Cited by 887 · see citing works

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B

Manno, C. S., Chew, A. J., Hutchison, S., Larson, P. J., Herzog, R. W., Arruda, V. R., Tai, S. J., Ragni, M. V., Thompson, A., Ozelo, M., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3296 · Cited by 749 · see citing works

AAV vector integration sites in mouse hepatocellular carcinoma

Donsante, A., Miller, D. G., Li, Y., Vogler, C., Brunt, E. M., Russell, D. W., & Sands, M. S. (2007) · Science · doi:10.1126/science.1142658 · Cited by 662 · see citing works

Expansions of transgene repeats cause heterochromatin formation and gene silencing in Drosophila

Dorer, D. R. (1994) · Cell · doi:10.1016/0092-8674(94)90439-1 · Cited by 504 · see citing works

Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo

Nakai, H., Yant, S. R., Storm, T. A., Fuess, S., Meuse, L., & Kay, M. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6969-6976.2001 · Cited by 478 · see citing works

Inactivation of gene expression in plants as a consequence of specific sequence duplication.

Flavell, R. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3490 · Cited by 466 · see citing works

Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver

Nathwani, A. C., Gray, J. T., Ng, C. Y., Zhou, J., Spence, Y., Waddington, S. N., Tuddenham, E. G. D., Kemball‐Cook, G., McIntosh, J., Boon‐Spijker, M., et al. (2005) · Blood · doi:10.1182/blood-2005-10-4035 · Cited by 421 · see citing works

Rapid Uncoating of Vector Genomes Is the Key toEfficient Liver Transduction with Pseudotyped Adeno-Associated VirusVectors

Thomas, C. E., Storm, T. A., Huang, Z., & Kay, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.3110-3122.2004 · Cited by 358 · see citing works

Unrestricted Hepatocyte Transduction with Adeno-Associated Virus Serotype 8 Vectors in Mice

Nakai, H., Fuess, S., Storm, T. A., Muramatsu, S., Nara, Y., & Kay, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.214-224.2005 · Cited by 322 · see citing works

Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates

Nathwani, A. C., Gray, J. T., McIntosh, J., Ng, C. Y., Zhou, J., Spence, Y., Cochrane, M., Gray, E., Tuddenham, E. G. D., & Davidoff, A. M. (2006) · Blood · doi:10.1182/blood-2006-03-010181 · Cited by 272 · see citing works

Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver

Mingozzi, F., Hasbrouck, N. C., Basner-Tschakarjan, E., Edmonson, S. A., Hui, D. J., Sabatino, D. E., Zhou, S., Wright, J. F., Jiang, H., Pierce, G. F., et al. (2007) · Blood · doi:10.1182/blood-2007-03-080093 · Cited by 254 · see citing works

Inhibitor development in haemophilia B: an orphan disease in need of attention

DiMichele, D. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06657.x · Cited by 252 · see citing works

Chromatin silencing and the maintenance of a functional germline in Caenorhabditis elegans

Kelly, W. G., & Fire, A. Z. (1998) · Development · doi:10.1242/dev.125.13.2451 · Cited by 245 · see citing works

Characterization of Adeno-Associated Virus Genomes Isolated from Human Tissues

Schnepp, B. C., Jensen, R. L., Chen, C.-L., Johnson, P. R., & Clark, K. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14793-14803.2005 · Cited by 231 · see citing works

Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models

Davidoff, A. M., Gray, J. T., Ng, C. Y., Zhang, Y., Zhou, J., Spence, Y., Bakar, Y., & Nathwani, A. C. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.12.022 · Cited by 218 · see citing works

Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid

Vandenberghe, L. H., Wang, L., Somanathan, S., Zhi, Y., Figueredo, J., Calcedo, R., Sanmiguel, J., Desai, R. A., Chen, C. S., Johnston, J., et al. (2006) · Nature Medicine · doi:10.1038/nm1445 · Cited by 208 · see citing works

Manufacturing and characterizing AAV-based vectors for use in clinical studies

Wright, J. F. (2008) · Gene Therapy · doi:10.1038/gt.2008.65 · Cited by 205 · see citing works

Large‐scale molecular characterization of adeno‐associated virus vector integration in mouse liver

Nakai, H., Wu, X., Fuess, S., Storm, T. A., Munroe, D., Montini, E., Burgess, S. M., Grompe, M., & Kay, M. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3606-3614.2005 · Cited by 190 · see citing works

Canine hemophilia B resulting from a point mutation with unusual consequences.

Evans, J. P., Brinkhous, K. M., Brayer, G. D., Reisner, H. M., & High, K. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10095 · Cited by 189 · see citing works

Latent Adeno-Associated Virus Infection Elicits Humoral but Not Cell-Mediated Immune Responses in a Nonhuman Primate Model

Hernandez, Y. J., Wang, J., Kearns, W. G., Loiler, S., Poirier, A. E., & Flotte, T. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8549-8558.1999 · Cited by 169 · see citing works

Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques

Nathwani, A. C., Davidoff, A. M., Hanawa, H., Hu, Y., Hoffer, F. A., Nikanorov, A. Y., Slaughter, C. A., Ng, C. Y., Zhou, J., Lozier, J. N., et al. (2002) · Blood · doi:10.1182/blood-2002-02-0589 · Cited by 164 · see citing works

A factor IX-deficient mouse model for hemophilia B gene therapy

Wang, L., Zoppè, M., Hackeng, T. M., Griffin, J. H., Lee, K., & Verma, I. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11563 · Cited by 164 · see citing works

Analysis of Tumors Arising in Male B6C3F1 Mice with and without AAV Vector Delivery to Liver

Bell, P. L., Moscioni, A. D., McCarter, R., Wu, D., Gao, G., Hoang, A., Sanmiguel, J. C., Sun, X., Wivel, N. A., Raper, S. E., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.008 · Cited by 150 · see citing works

Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA

Nathwani, A. C., Davidoff, A. M., Hanawa, H., Zhou, J., Vanin, E. F., & Nienhuis, A. W. (2001) · Blood · doi:10.1182/blood.v97.5.1258 · Cited by 143 · see citing works

Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy

Waddington, S. N. (2004) · Blood · doi:10.1182/blood-2004-02-0627 · Cited by 139 · see citing works

No Evidence for Tumorigenesis of AAV Vectors in a Large-Scale Study in Mice

Bell, P. L., Wang, L., Lebherz, C., Flieder, D. B., Bove, M. S., Wu, D., Gao, G. P., Wilson, J. M., & Wivel, N. A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.020 · Cited by 135 · see citing works

The Pleiotropic Effects of Natural AAV Infections on Liver-directed Gene Transfer in Macaques

Wang, L., Calcedo, R., Wang, H., Bell, P., Grant, R., Vandenberghe, L. H., Sanmiguel, J., Morizono, H., Batshaw, M. L., & Wilson, J. M. (2010) · Molecular Therapy · doi:10.1038/mt.2009.245 · Cited by 130 · see citing works

Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B

Arruda, V. R., Stedman, H. H., Haurigot, V., Buchlis, G., Baila, S., Favaro, P. M. B., Chen, Y.-F., Franck, H. W. G., Zhou, S., Wright, J. F., et al. (2010) · Blood · doi:10.1182/blood-2009-12-261156 · Cited by 115 · see citing works

Lifespan, age changes and tumour incidence in an ageing C57BL mouse colony

Rowlatt, C., Chesterman, F. C., & Sheriff, M. U. (1976) · Laboratory Animals · doi:10.1258/002367776780956917 · Cited by 115 · see citing works

In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor

Waddington, S. N., Buckley, S. M. K., Nivsarkar, M. S., Jezzard, S., Schneider, H., Dahse, T., Kemball‐Cook, G., Miah, M., Tucker, N., Dallman, M. J., et al. (2003) · Blood · doi:10.1182/blood-2002-03-0779 · Cited by 113 · see citing works

The Morphology, Immunohistochemistry, and Incidence of Hematopoietic Neoplasms in Mice and Rats

Frith, C. H., Ward, J. M., & Chandra, M. (1993) · Toxicologic Pathology · doi:10.1177/019262339302100213 · Cited by 91 · see citing works

Evidence for Repeat-Induced Gene Silencing in Cultured Mammalian Cells: Inactivation of Tandem Repeats of Transfected Genes

McBurney, M. W., Mai, T., Yang, X., & Jardine, K. E. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5443 · Cited by 85 · see citing works

Targeted Inactivation of the Coagulation Factor IX Gene Causes Hemophilia B in Mice

Kundu, R. K., Sangiorgi, F. O., Wu, L.-Y., Kurachi, K., Anderson, W. F., Maxson, R. E., & Gordon, E. M. (1998) · Blood · doi:10.1182/blood.v92.1.168.413k06_168_174 · Cited by 81 · see citing works

Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38− subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV

Nathwani, A. C., Hanawa, H., Vandergriff, J. A., Kelly, P., Vanin, E. F., & Nienhuis, A. W. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301068 · Cited by 78 · see citing works

Enhancing transduction of the liver by adeno-associated viral vectors

Nathwani, A. C., Cochrane, M., McIntosh, J., Ng, C. Y. C., Zhou, J., Gray, J. T., & Davidoff, A. M. (2009) · Gene Therapy · doi:10.1038/gt.2008.137 · Cited by 77 · see citing works

Prospects for gene therapy of haemophilia

Nathwani, A., Davidoff, A., & Tuddenham, E. (2004) · Haemophilia · doi:10.1111/j.1365-2516.2004.00926.x · Cited by 60 · see citing works

Infectious Titer Assay for Adeno-Associated Virus Vectors with Sensitivity Sufficient to Detect Single Infectious Events

Zhen, Z., Espinoza, Y., Bleu, T., Sommer, J. M., & Wright, J. F. (2004) · Human Gene Therapy · doi:10.1089/1043034041361262 · Cited by 51 · see citing works

Diversity of homology-dependent gene silencing strategies in fungi

Faugeron, G. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00066-7 · Cited by 47 · see citing works

Current status and prospects for gene therapy

Nathwani, A., Benjamin, R., Nienhuis, A., & Davidoff, A. (2004) · Vox Sanguinis · doi:10.1111/j.1423-0410.2004.00543.x · Cited by 32 · see citing works

Neonatal Intravenous Injection of a Gammaretroviral Vector Has a Low Incidence of Tumor Induction in Mice

Tittiger, M. E., Ma, X., Xu, L., & Ponder, K. P. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.070 · Cited by 8 · see citing works

Translocations of 17q21∼qter in neuroblastoma cell lines infrequently include the topoisomerase IIα gene

Yoon, K. J., Danks, M. K., Ragsdale, S. T., Valentine, M. B., & Valentine, V. A. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.11.004 · Cited by 6 · see citing works

Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B

Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108046 · Cited by 1,864 · see citing works

Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B

Nathwani, A. C., Reiss, U. M., Tuddenham, E. G. D., Rosales, C., Chowdary, P., McIntosh, J., Della Peruta, M., Lheriteau, E., Patel, N., Raj, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407309 · Cited by 1,273 · see citing works

Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain

Deverman, B. E., Pravdo, P. L., Simpson, B. P., Kumar, S. R., Chan, K. Y., Banerjee, A., Wu, W.-L., Yang, B., Huber, N., Pasca, S. P., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3440 · Cited by 1,061 · see citing works

Emerging issues in AAV-mediated in vivo gene therapy

Colella, P., Ronzitti, G., & Mingozzi, F. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.007 · Cited by 881 · see citing works

Current clinical applications of in vivo gene therapy with AAVs

Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.007 · Cited by 743 · see citing works

Prevention of muscular dystrophy in mice by CRISPR/Cas9–mediated editing of germline DNA

Long, C., McAnally, J. R., Shelton, J. M., Mireault, A. A., Bassel-Duby, R., & Olson, E. N. (2014) · Science · doi:10.1126/science.1254445 · Cited by 720 · see citing works

AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer

Costa Verdera, H., Kuranda, K., & Mingozzi, F. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.12.010 · Cited by 641 · see citing works

Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain

Aschauer, D. F., Kreuz, S., & Rumpel, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076310 · Cited by 522 · see citing works

AAV vectors: The Rubik’s cube of human gene therapy

Pupo, A., Fernández, A., Low, S. H., François, A., Suárez-Amarán, L., & Samulski, R. J. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.09.015 · Cited by 361 · see citing works

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors

Ronzitti, G., Gross, D.-A., & Mingozzi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00670 · Cited by 357 · see citing works

Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys

Mingozzi, F., Anguela, X. M., Pavani, G., Chen, Y., Davidson, R. J., Hui, D. J., Yazicioglu, M., Elkouby, L., Hinderer, C. J., Faella, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005795 · Cited by 355 · see citing works

IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies

Leborgne, C., Barbon, E., Alexander, J. M., Hanby, H., Delignat, S., Cohen, D. M., Collaud, F., Muraleetharan, S., Lupo, D., Silverberg, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0911-7 · Cited by 336 · see citing works

Gene therapy for neurological disorders: progress and prospects

Deverman, B. E., Ravina, B. M., Bankiewicz, K. S., Paul, S. M., & Sah, D. W. Y. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.110 · Cited by 306 · see citing works

Manufacturing of recombinant adeno-associated viral vectors for clinical trials

Clément, N., & Grieger, J. C. (2016) · Molecular Therapy - Methods & Clinical Development · doi:10.1038/mtm.2016.2 · Cited by 286 · see citing works

Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant

McIntosh, J., Lenting, P. J., Rosales, C., Lee, D., Rabbanian, S., Raj, D., Patel, N., Tuddenham, E. G. D., Christophe, O. D., McVey, J. H., et al. (2013) · Blood · doi:10.1182/blood-2012-10-462200 · Cited by 278 · see citing works

Erratum: Gene therapy for neurological disorders: progress and prospects

Deverman, B. E., Ravina, B. M., Bankiewicz, K. S., Paul, S. M., & Sah, D. W. Y. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.158 · Cited by 248 · see citing works

Clinical development of gene therapy: results and lessons from recent successes

Kumar, S. R. P., Markusic, D. M., Biswas, M., High, K. A., & Herzog, R. W. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.34 · Cited by 235 · see citing works

Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy

Haurigot, V., Marcó, S., Ribera, A., Garcia, M., Ruzo, A., Villacampa, P., Ayuso, E., Añor, S., Andaluz, A., Pineda, M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66778 · Cited by 215 · see citing works

Evaluating the state of the science for adeno-associated virus integration: An integrated perspective

Sabatino, D. E., Bushman, F. D., Chandler, R. J., Crystal, R. G., Davidson, B. L., Dolmetsch, R. E., Eggan, K. C., Gao, G., Gil-Fariña, I., Kay, M. A., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.06.004 · Cited by 213 · see citing works

Sonoporation: mechanistic insights and ongoing challenges for gene transfer.

Delalande, A., Kotopoulis, S., Postema, M., Midoux, P., & Pichon, C. (2013) · Gene · doi:10.1016/j.gene.2013.03.095 · Cited by 198 · see citing works

Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction

Fitzpatrick, Z., Leborgne, C., Barbon, E., Masat, E., Ronzitti, G., van Wittenberghe, L., Vignaud, A., Collaud, F., Charles, S., Simon Sola, M., et al. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2018.02.003 · Cited by 192 · see citing works

BAX 335 hemophilia b gene therapy clinical trial results: Potential impact of CpG sequences on gene expression

Konkle, B. A., Walsh, C. E., Escobar, M. A., Josephson, N. C., Young, G., von Drygalski, A., McPhee, S. W. J., Samulski, R. J., Bilic, I., de la Rosa, M., et al. (2021) · Blood · doi:10.1182/blood.2019004625 · Cited by 189 · see citing works

From Clinical Trials to Clinical Practice: Practical Considerations for Gene Replacement Therapy in SMA Type 1

Al-Zaidy, S. A., & Mendell, J. R. (2019) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.06.007 · Cited by 183 · see citing works

Displaying High-affinity Ligands on Adeno-associated Viral Vectors Enables Tumor Cell-specific and Safe Gene Transfer

Münch, R. C., Janicki, H., Völker, I., Rasbach, A., Hallek, M. J., Büning, H., & Buchholz, C. J. (2012) · Molecular Therapy · doi:10.1038/mt.2012.186 · Cited by 176 · see citing works

Innate Immune Responses to AAV Vectors

Rogers, G. L., Martino, A. T., Aslanidi, G. V., Jayandharan, G. R., Srivastava, A., & Herzog, R. W. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00194 · Cited by 178 · see citing works

Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery

Nidetz, N. F., McGee, M. C., Tse, L. V., Li, C., Cong, L., Li, Y., & Huang, W. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107453 · Cited by 174 · see citing works

Towards translational optogenetics

Bansal, A., Shikha, S., & Zhang, Y. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00829-3 · Cited by 173 · see citing works

Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells

Martino, A. T., Basner-Tschakarjan, E., Markusic, D. M., Finn, J. D., Hinderer, C., Zhou, S., Ostrov, D. A., Srivastava, A., Ertl, H. C. J., Terhorst, C., et al. (2013) · Blood · doi:10.1182/blood-2012-10-460733 · Cited by 162 · see citing works

Adeno-associated virus serotypes for gene therapeutics

Lisowski, L., Tay, S. S., & Alexander, I. E. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.07.006 · Cited by 159 · see citing works

Next-generation AAV vectors—Do not judge a virus (only) by its cover

Domenger, C., & Grimm, D. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz148 · Cited by 147 · see citing works

Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration

Greig, J., Martins, K. M., Breton, C., Lamontagne, R. J., Zhu, Y.-Q., He, Z., White, J., Zhu, J., Chichester, J. A., Zheng, Q., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01974-7 · Cited by 117 · see citing works

Durability of transgene expression after rAAV gene therapy

Muhuri, M., Lévy, D., Schulz, M., McCarty, D. M., & Gao, G. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.03.004 · Cited by 148 · see citing works

AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges

Kang, L., Jin, S., Wang, J., Lv, Z., Xin, C., Tan, C., Zhao, M., Wang, L., & Liu, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.067 · Cited by 131 · see citing works

Therapeutic hFIX activity achieved after single AAV5-hFIX treatment in hemophilia b patients and NHPs with pre-existing anti-AAV5 NABs

Majowicz, A., Nijmeijer, B., Lampen, M. H., Spronck, L., de Haan, M., Petry, H., van Deventer, S. J., Meyer, C., Tangelder, M., & Ferreira, V. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.05.009 · Cited by 126 · see citing works

Double-stranded RNA innate immune response activation from long-term adeno-associated virus vector transduction

Shao, W., Earley, L. F., Chai, Z., Chen, X., Sun, J., He, T., Deng, M., Hirsch, M. L., Ting, J., Samulski, R. J., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120474 · Cited by 119 · see citing works

Challenges Posed by Immune Responses to AAV Vectors: Addressing Root Causes

Hamilton, B. A., & Wright, J. F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.675897 · Cited by 118 · see citing works

Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper

Yang, T., Braun, M., Lembke, W., McBlane, F., Kamerud, J., DeWall, S. L., Tarcsa, E., Fang, X., Hofer, L., Kavita, U., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.07.018 · Cited by 118 · see citing works

Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid

Vercauteren, K., Hoffman, B. E., Zolotukhin, I., Keeler, G. D., Xiao, J. W., Basner-Tschakarjan, E., High, K. A., Ertl, H. C., Rice, C. M., Srivastava, A., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.61 · Cited by 114 · see citing works

Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia b

Mingozzi, F., Chen, Y., Murphy, S. L., Edmonson, S. C., Tai, A., Price, S. D., Metzger, M. E., Zhou, S., Wright, J. F., Donahue, R. E., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.84 · Cited by 112 · see citing works

Integration Frequency and Intermolecular Recombination of rAAV Vectors in Non-human Primate Skeletal Muscle and Liver

Nowrouzi, A., Penaud‐Budloo, M., Kaeppel, C., Appelt, U., Guiner, C. L., Moullier, P., Kalle, C. V., Snyder, R. O., & Schmidt, M. (2012) · Molecular Therapy · doi:10.1038/mt.2012.47 · Cited by 111 · see citing works

Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects

Baruteau, J., Waddington, S. N., Alexander, I. E., & Gissen, P. (2017) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-017-0053-3 · Cited by 108 · see citing works

Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes

Lempp, F. A., Wiedtke, E., Qu, B., Roques, P., Chemin, I., Vondran, F. W. R., Grand, R. L., Grimm, D., & Urban, S. (2017) · Hepatology · doi:10.1002/hep.29112 · Cited by 108 · see citing works

Induction of hepatocellular carcinoma by in vivo gene targeting

Wang, P.-R., Xu, M., Toffanin, S., Li, Y., Llovet, J. M., & Russell, D. W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117032109 · Cited by 105 · see citing works

Advances and challenges for hemophilia gene therapy

Batty, P. A., & Lillicrap, D. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz157 · Cited by 103 · see citing works

Strategy to detect pre-existing immunity to AAV gene therapy

Falese, L., Sandza, K., Yates, B., Triffault, S., Gangar, S., Long, B., Tsuruda, L., Carter, B., Vettermann, C., Zoog, S. J., et al. (2017) · Gene Therapy · doi:10.1038/gt.2017.95 · Cited by 101 · see citing works

Systemic errors in quantitative polymerase chain reaction titration of self-complementary adeno-associated viral vectors and improved alternative methods

Fagone, P., Wright, J. F., Nathwani, A. C., Nienhuis, A. W., Davidoff, A. M., & Gray, J. T. (2012) · Human Gene Therapy Methods · doi:10.1089/hgtb.2011.104 · Cited by 97 · see citing works

CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration

Koo, T., Park, S. W., Jo, D. H., Kim, D., Kim, J. H., Cho, H.-Y., Kim, J. H., Kim, J. H., & Kim, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04175-y · Cited by 95 · see citing works

Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions

Basner‐Tschakarjan, E., & Mingozzi, F. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00350 · Cited by 95 · see citing works

Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera ® )

Salmon, F., Grosios, K., & Petry, H. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.852065 · Cited by 93 · see citing works

AAV vector development, back to the future

Suárez-Amarán, L., Song, L., Tretiakova, A. P., Mikhail, S., & Samulski, R. J. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.064 · Cited by 87 · see citing works

Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for Hemophilia

Monahan, P. E., Négrier, C., Tarantino, M. D., Valentino, L. A., & Mingozzi, F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112471 · Cited by 85 · see citing works

Gene Therapy with BMN 270 Results in Therapeutic Levels of FVIII in Mice and Primates and Normalization of Bleeding in Hemophilic Mice

Bunting, S., Zhang, L., Xie, L. Y., Bullens, S., Mahimkar, R., Fong, S., Sandza, K., Harmon, D., Yates, B., Handyside, B., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.12.009 · Cited by 83 · see citing works

First-in-human in vivo genome editing via AAV-zinc-finger nucleases for mucopolysaccharidosis I/II and hemophilia B

Harmatz, P., Prada, C. E., Burton, B. K., Lau, H., Kessler, C. M., Cao, L., Falaleeva, M., Villegas, A. G., Zeitler, J., Meyer, K. E., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.10.010 · Cited by 84 · see citing works

Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial

Xue, F., Li, H., Wu, X., Liu, W. Y., Zhang, F., Tang, D., Chen, Y., Wang, W., Chi, Y., Zheng, J., et al. (2022) · The Lancet Haematology · doi:10.1016/s2352-3026(22)00113-2 · Cited by 82 · see citing works

Liver induced transgene tolerance with AAV vectors

Keeler, G. D., Markusic, D. M., & Hoffman, B. E. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2017.12.002 · Cited by 81 · see citing works

Age-Related Seroprevalence of Antibodies Against AAV-LK03 in a UK Population Cohort

Perocheau, D. P., Cunningham, S. C., Lee, J., Antinao Diaz, J., Waddington, S. N., Gilmour, K., Eaglestone, S., Lisowski, L., Thrasher, A. J., Alexander, I. E., et al. (2019) · Human Gene Therapy · doi:10.1089/hum.2018.098 · Cited by 81 · see citing works

The prevalence of neutralizing antibodies against adeno‐associated virus capsids is reduced in young Japanese individuals

Mimuro, J., Mizukami, H., Shima, M., Matsushita, T., Taki, M., Muto, S., Higasa, S., Sakai, M., Ohmori, T., Madoiwa, S., et al. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23818 · Cited by 77 · see citing works

Nucleic acid therapeutics: Past, present, and future

Naeem, S., Zhang, J., Zhang, Y., & Wang, Y. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102440 · Cited by 78 · see citing works

The impact of pre-existing immunity on the non-clinical pharmacodynamics of AAV5-based gene therapy

Long, B. R., Sandza, K., Holcomb, J., Crockett, L., Hayes, G. M., Arens, J., Fonck, C., Tsuruda, L. S., Schweighardt, B., O’Neill, C. A., et al. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.03.006 · Cited by 75 · see citing works

Synergistic effects of central nervous system‐directed gene therapy and bone marrow transplantation in the murine model of infantile neuronal ceroid lipofuscinosis

Macauley, S. L., Roberts, M. S., Wong, A. M. S., McSloy, F., Reddy, A. S., Cooper, J. D., & Sands, M. S. (2012) · Annals of Neurology · doi:10.1002/ana.23545 · Cited by 75 · see citing works

Minimizing the Inhibitory Effect of Neutralizing Antibody for Efficient Gene Expression in the Liver With Adeno-associated Virus 8 Vectors

Mimuro, J., Mizukami, H., Hishikawa, S., Ikemoto, T., Ishiwata, A., Sakata, A., Ohmori, T., Madoiwa, S., Ono, F., Ozawa, K., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.258 · Cited by 74 · see citing works

Stable Human FIX Expression After 0.9G Intrauterine Gene Transfer of Self-complementary Adeno-associated Viral Vector 5 and 8 in Macaques

Mattar, C. N. Z., Nathwani, A. C., Waddington, S. N., Dighe, N., Kaeppel, C., Nowrouzi, A., McIntosh, J., Johana, N. B., Ogden, B. E., Fisk, N. M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.107 · Cited by 74 · see citing works

Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5 ch and AAV1

Majowicz, A., Salas, D., Zabaleta, N., Rodríguez‐García, E., González‐Aseguinolaza, G., Petry, H., & Ferreira, V. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.05.003 · Cited by 73 · see citing works

Current status of haemophilia gene therapy

High, K. A., Nathwani, A. C., Spencer, H. T., & Lillicrap, D. (2014) · Haemophilia · doi:10.1111/hae.12411 · Cited by 73 · see citing works

Inhibitors in Hemophilia B

Quintavalle, G., Castaman, G., Baldacci, E., Ferretti, A., Riccardi, F., Tagliaferri, A., & Santoro, C. (2018) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0038-1660817 · Cited by 73 · see citing works

Therapeutic efficacy of AAV-mediated restoration of PKP2 in arrhythmogenic cardiomyopathy

Kyriakopoulou, E., Versteeg, D., de Ruiter, H., Perini, I., Seibertz, F., Döring, Y., Zentilin, L., Tsui, H., van Kampen, S. J., Tiburcy, M., et al. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00378-9 · Cited by 73 · see citing works

Insight into the mechanisms of enhanced retinal transduction by the engineered AAV2 capsid variant -7m8

Khabou, H., Desrosiers, M., Winckler, C., Fouquet, S., Auregan, G., Bemelmans, A., Sahel, J., & Dalkara, D. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26031 · Cited by 71 · see citing works

Mir‐142‐3p target sequences reduce transgene‐directed immunogenicity following intramuscular adeno‐associated virus 1 vector‐mediated gene delivery

Majowicz, A., Maczuga, P., Kwikkers, K. L., van der Marel, S., van Logtenstein, R., Petry, H., van Deventer, S. J. H., Konstantinova, P. S., & Ferreira, V. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2712 · Cited by 69 · see citing works

Adeno-associated virus gene therapy prevents progression of kidney disease in genetic models of nephrotic syndrome

Ding, W. Y., Kuzmuk, V., Hunter, S., Lay, A. C., Hayes, B. L., Beesley, M., Rollason, R., Hurcombe, J., Barrington, F., Masson, C., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abc8226 · Cited by 70 · see citing works

Emerging approaches for restoration of hearing and vision

Kleinlogel, S., Vogl, C., Jeschke, M., Neef, J., & Moser, T. (2020) · Physiological Reviews · doi:10.1152/physrev.00035.2019 · Cited by 68 · see citing works

Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes

Dane, A. P., Wowro, S. J., Cunningham, S. C., & Alexander, I. E. (2012) · Gene Therapy · doi:10.1038/gt.2012.67 · Cited by 69 · see citing works

Gene therapy for immune tolerance induction in hemophilia with inhibitors

Arruda, V. R., & Samelson-Jones, B. J. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13331 · Cited by 69 · see citing works

Adeno-Associated Virus (AAV)-Mediated Gene Therapy for Duchenne Muscular Dystrophy: The Issue of Transgene Persistence

Manini, A., Abati, E., Nuredini, A., Corti, S. P., & Comi, G. P. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.814174 · Cited by 66 · see citing works

Animal Models of Hemophilia

Sabatino, D. E., Nichols, T. C., Merricks, E. P., Bellinger, D. A., Herzog, R. W., & Monahan, P. E. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00006-8 · Cited by 67 · see citing works

Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B

Reiss, U. M., Davidoff, A. M., Tuddenham, E. G. D., Chowdary, P., McIntosh, J., Muczynski, V., Journou, M., Simini, G., Ireland, L., Mohamed, S., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2414783 · Cited by 66 · see citing works

Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler–Najjar Syndrome

Aronson, S. J., Veron, P., Collaud, F., Hubert, A., Delahais, V., Honnet, G., de Knegt, R. J., Junge, N., Baumann, U., Giorgio, A. D., et al. (2019) · Human Gene Therapy · doi:10.1089/hum.2019.143 · Cited by 65 · see citing works

The Threefold Protrusions of Adeno-Associated Virus Type 8 Are Involved in Cell Surface Targeting as Well as Postattachment Processing

Raupp, C., Naumer, M., Müller, O. J., Gurda, B. L., Agbandje‐McKenna, M., & Kleinschmidt, J. A. (2012) · Journal of Virology · doi:10.1128/jvi.00209-12 · Cited by 63 · see citing works

Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies

Kishimoto, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00969 · Cited by 63 · see citing works

An Engineered Virus Library as a Resource for the Spectrum-wide Exploration of Virus and Vector Diversity

Zhang, W., Fu, J., Liu, J., Wang, H., Schiwon, M., Janz, S., Schaffarczyk, L., von der Goltz, L., Ehrke‐Schulz, E., Doerner, J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.008 · Cited by 61 · see citing works

Complexity of immune responses to AAV transgene products – Example of factor IX

Herzog, R. W. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2017.05.006 · Cited by 60 · see citing works

Advances in Gene Therapy for Hemophilia

Nathwani, A. C., Davidoff, A. M., & Tuddenham, E. G. D. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.167 · Cited by 60 · see citing works

Immunoadsorption enables successful rAAV5-mediated repeated hepatic gene delivery in nonhuman primates

Salas, D., Kwikkers, K. L., Zabaleta, N., Bazo, A., Petry, H., van Deventer, S. J., Aseguinolaza, G. G., & Ferreira, V. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000380 · Cited by 59 · see citing works

Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseases

Caneva, A. D., Porro, F., Bortolussi, G., Sola, R., Lisjak, M., Barzel, A., Giacca, M., Kay, M. A., Vlahoviček, K., Zentilin, L., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128863 · Cited by 59 · see citing works

Long-term stable reduction of low-density lipoprotein in nonhuman primates following in vivo genome editing of PCSK9

Wang, L., Breton, C. A., Warzecha, C. C., Bell, P. L., Yan, H., He, Z., White, J., Zhu, Y., Li, M., Buza, E. L., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.02.020 · Cited by 59 · see citing works

Molybdenum Cofactor Deficiency in Humans

Johannes, L., Fu, C.-Y., & Schwarz, G. (2022) · Molecules · doi:10.3390/molecules27206896 · Cited by 59 · see citing works

Platelet Gene Therapy by Lentiviral Gene Delivery to Hematopoietic Stem Cells Restores Hemostasis and Induces Humoral Immune Tolerance in FIXnull Mice

Chen, Y., Schroeder, J. A., Kuether, E. L., Zhang, G., & Shi, Q. (2013) · Molecular Therapy · doi:10.1038/mt.2013.197 · Cited by 59 · see citing works

Comparison of adeno-associated virus serotypes and delivery methods for cardiac gene transfer

Fang, H., Lai, N. C., Gao, M. H., Miyanohara, A., Roth, D. M., Tang, T., & Hammond, H. K. (2012) · Human Gene Therapy Methods · doi:10.1089/hgtb.2012.105 · Cited by 58 · see citing works

Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia B

Schmidt, M., Foster, G. R., Coppens, M., Thomsen, H., Dolmetsch, R. E., Heijink, L., Monahan, P. E., & Pipe, S. W. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023009876 · Cited by 58 · see citing works

The Role of Recombinant AAV in Precise Genome Editing

Bijlani, S., Pang, K. M., Sivanandam, V., Singh, A., & Chatterjee, S. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.799722 · Cited by 58 · see citing works

Gene therapy for hemophilia

Herzog, R. W. (2015) · Frontiers in bioscience · doi:10.2741/4324 · Cited by 56 · see citing works

Current and Emerging Strategies for Enhancing Antibody Delivery to the Brain

Bajracharya, R., Caruso, A. C., Vella, L. J., & Nisbet, R. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122014 · Cited by 55 · see citing works

Hemophilia A gene therapy: current and next-generation approaches

Pipe, S. W., Gonen-Yaacovi, G., & Segurado, O. G. (2021) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2002842 · Cited by 55 · see citing works

AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage

Binny, C., McIntosh, J., Peruta, M. D., Kymäläinen, H., Tuddenham, E. G. D., Buckley, S. M. K., Waddington, S. N., McVey, J. H., Spence, Y., Morton, C. L., et al. (2011) · Blood · doi:10.1182/blood-2011-09-377630 · Cited by 54 · see citing works

Development of gene therapy for blood disorders: an update

Nienhuis, A. W. (2013) · Blood · doi:10.1182/blood-2013-04-453209 · Cited by 54 · see citing works

In Utero Transfer of Adeno-Associated Viral Vectors Produces Long-Term Factor IX Levels in a Cynomolgus Macaque Model

Mattar, C. N. Z., Gil-Fariña, I., Rosales, C., Johana, N. B., Tan, Y., McIntosh, J., Kaeppel, C., Waddington, S. N., Biswas, A., Choolani, M. A., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.04.003 · Cited by 54 · see citing works

Cardiac Gene Transfer of Short Hairpin RNA Directed Against Phospholamban Effectively Knocks Down Gene Expression but Causes Cellular Toxicity in Canines

Bish, L. T., Sleeper, M. M., Reynolds, C., Gazzara, J. A., Withnall, E., Singletary, G. E., Buchlis, G., Hui, D. J., High, K. A., Gao, G., et al. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.035 · Cited by 54 · see citing works

The experiences of people with haemophilia and their families of gene therapy in a clinical trial setting: regaining control, the Exigency study

Fletcher, S. J., Jenner, K., Pembroke, L., Holland, M., & Khair, K. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02256-2 · Cited by 57 · see citing works

Progress and challenges of gene therapy for Pompe disease

Ronzitti, G., Collaud, F., Laforêt, P., & Mingozzi, F. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.04.67 · Cited by 52 · see citing works

Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction

Muhuri, M., Zhan, W., Maeda, Y., Li, J., Lotun, A., Chen, J., Sylvia, K., Dasgupta, I., Arjomandnejad, M., Nixon, T., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.674242 · Cited by 50 · see citing works

Timing of Intensive Immunosuppression Impacts Risk of Transgene Antibodies after AAV Gene Therapy in Nonhuman Primates

Samelson-Jones, B. J., Finn, J. D., Favaro, P., Wright, J. F., & Arruda, V. R. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.05.001 · Cited by 50 · see citing works

Translocations of 17q21∼qter in neuroblastoma cell lines infrequently include the topoisomerase IIα gene

Yoon, K. J., Danks, M. K., Ragsdale, S. T., Valentine, M. B., & Valentine, V. A. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.11.004 · Cited by 6 · see citing works

Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates

Nathwani, A. C., Gray, J. T., McIntosh, J., Ng, C. Y., Zhou, J., Spence, Y., Cochrane, M., Gray, E., Tuddenham, E. G. D., & Davidoff, A. M. (2006) · Blood · doi:10.1182/blood-2006-03-010181 · Cited by 272 · see citing works

Dose response results of self complementary adeno‐associated virus (AAV) vector‐mediated factor IX gene transfer in non‐human primates

Reiss, U. M., Davidoff, A. M., Gray, J. T., Nienhuis, A. W., & Nathwani, A. C. (2009) · Haemophilia · doi:10.1111/j.1365-2516.2009.01996_6.x

Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques

Nathwani, A. C., Davidoff, A. M., Hanawa, H., Hu, Y., Hoffer, F. A., Nikanorov, A. Y., Slaughter, C. A., Ng, C. Y., Zhou, J., Lozier, J. N., et al. (2002) · Blood · doi:10.1182/blood-2002-02-0589 · Cited by 164 · see citing works

Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver

Nathwani, A. C., Gray, J. T., Ng, C. Y., Zhou, J., Spence, Y., Waddington, S. N., Tuddenham, E. G. D., Kemball‐Cook, G., McIntosh, J., Boon‐Spijker, M., et al. (2005) · Blood · doi:10.1182/blood-2005-10-4035 · Cited by 421 · see citing works